ey0015.4-2 | Important for clinical practice | ESPEYB15
W Bonfig , A Lindberg , M Carlsson , W Cutfield , D Dunger , C Camacho-Hübner , RW Holl
ey0015.4-11 | New perspectives | ESPEYB15
SE Stalman , N Solanky , M Ishida , C Alemán-Charlet , S Abu-Amero , M Alders , L Alvizi , W Baird , C Demetriou , P Henneman , C James , LC Knegt , LJ Leon , MMAM Mannens , AN Mul , NA Nibbering , E Peskett , FI Rezwan , C Ris-Stalpers , JAM van der Post , GA Kamp , FB Plötz , JM Wit , P Stanier , GE Moore , RC Hennekam
ey0015.9-7 | Growth, growth hormone and puberty in chronic diseases: novel insights from clinical practice | ESPEYB15
H David , C Aupiais , B Louveau , P Quartier , E Jacqz-Aigrain , JC Carel , D Simon
ey0015.9-9 | Growth, growth hormone and puberty in chronic diseases: novel insights from clinical practice | ESPEYB15
C Bizzarri , A Lonero , M Delvecchio , L Cavallo , MF Faienza , M Giordano , L Dello Strologo , M Cappa
ey0015.11-2 | New insight into obesity comorbidities | ESPEYB15
G Zabarsky , C Beek , E Hagman , B Pierpoint , S Caprio , R Weiss
ey0015.13-13 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
ME Robinson , K Altenor , C Carpenter , R Bonnell , E Jean-Baptiste , J von Oettingen
ey0015.13-14 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
E Wheeler , A Leong , CT Liu , MF Hievert , R Strawbridge , C Podmore
ey0020.4-13 | Effects of Hormone Intervention on the Immune System | ESPEYB20
GA Robinson , J Peng , H Peckham , G Butler , I Pineda-Torra , C Ciurtin , EC Jury
ey0020.5-5 | Clinical Guidance and Studies | ESPEYB20
CP Hagen , MB Fischer , C Wohlfahrt-Veje , M Assens , AS Busch , AT Pedersen , A Juul , KM Main
ey0020.7-9 | Bone Health in Inflammatory Bowel Disease | ESPEYB20
GV Sigurdsson , S Schmidt , D Mellstrom , C Ohlsson , R Saalman , M Lorentzon